Grant: Discovery Grants Program - Individual
Institut national de la recherche scientifique
$30,000.00
Virulence mechanisms of pathogenic escherichia coli infecting poultry
EF 2008-09
Résumé
Bacterial pathogens such as Escherichia coli cause a wide array of diseases in humans and domestic animals. E. coli is a highly adaptive bacterial species that is both a member of the normal intestinal flora and a versatile pathogen associated with numerous types of gastrointestinal and extra-intestinal diseases such as urinary tract infections, meningitis, septicaemia, and haemolytic uremic syndrome.
The spectrum of diseases caused by different types of E. coli strains is due to the acquisition of specific virulence genes that are absent from the non-pathogenic strains. Current knowledge suggests numerous putative virulence systems may be commonly used by pathogenic E. coli to cause diseases in either humans or livestock. However, the specific mechanisms by which pathogenic E. coli cause extra-intestinal disease in humans and animals are poorly understood. The long-term objective of our research is to identify and further understand the key factors that permit pathogenic E. coli strains to cause extra-intestinal disease. The short-term goals of our research are to determine the specific role of putative virulence genes from a Escherichia coli strain that causes extra-intestinal disease in poultry. Importantly, many of the uncharacterised pathogen-specific genes we have identified from the avian pathogenic E. coli strain are also present in E. coli strains causing human extra-intestinal disease. By using molecular biology techniques, we have identified pathogen-specific genes that are expressed by an avian E. coli strain within the extra-intestinal tissues of infected chickens. Once these potential virulence regions are identified, we inactivate or delete these specific regions and determine if they contribute to the capacity of the strain to cause disease in chickens. We anticipate our research will lead to better diagnostics to differentiate extra-intestinal E. coli pathogens from non-pathogenic E. coli strains. Further, discovery of novel proteins required and produced by pathogenic E. coli during infection may lead to the development of effective vaccines against this important pathogen of humans and livestock.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
250129-2007
Name nom
Dozois, Charles
Department département
INRS-Institut Armand-Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
30000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
2
Nb partie
5
Application title
Virulence mechanisms of pathogenic escherichia coli infecting poultry
Keyword
NA
Application summary
Bacterial pathogens such as Escherichia coli cause a wide array of diseases in humans and domestic animals. E. coli is a highly adaptive bacterial species that is both a member of the normal intestinal flora and a versatile pathogen associated with numerous types of gastrointestinal and extra-intestinal diseases such as urinary tract infections, meningitis, septicaemia, and haemolytic uremic syndrome.
The spectrum of diseases caused by different types of E. coli strains is due to the acquisition of specific virulence genes that are absent from the non-pathogenic strains. Current knowledge suggests numerous putative virulence systems may be commonly used by pathogenic E. coli to cause diseases in either humans or livestock. However, the specific mechanisms by which pathogenic E. coli cause extra-intestinal disease in humans and animals are poorly understood. The long-term objective of our research is to identify and further understand the key factors that permit pathogenic E. coli strains to cause extra-intestinal disease. The short-term goals of our research are to determine the specific role of putative virulence genes from a Escherichia coli strain that causes extra-intestinal disease in poultry. Importantly, many of the uncharacterised pathogen-specific genes we have identified from the avian pathogenic E. coli strain are also present in E. coli strains causing human extra-intestinal disease. By using molecular biology techniques, we have identified pathogen-specific genes that are expressed by an avian E. coli strain within the extra-intestinal tissues of infected chickens. Once these potential virulence regions are identified, we inactivate or delete these specific regions and determine if they contribute to the capacity of the strain to cause disease in chickens. We anticipate our research will lead to better diagnostics to differentiate extra-intestinal E. coli pathogens from non-pathogenic E. coli strains. Further, discovery of novel proteins required and produced by pathogenic E. coli during infection may lead to the development of effective vaccines against this important pathogen of humans and livestock.